This postdoctoral researcher explores how cancer cells adapt their metabolism to survive therapy and overcome drug resistance in hematologic malignancies.
PALO ALTO, Calif.-- (BUSINESS WIRE)--Greenstone Biosciences, Inc. announces a collaboration with Intel Corp. (NASDAQ: INTC) to accelerate AI-enabled drug discovery using Greenstone’s large-scale, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results